Successful response to tralokinumab in patients unresponsive, intolerant or with contraindications to dupilumab and JAK inhibitors: A case series.
J Eur Acad Dermatol Venereol
; 2024 Feb 29.
Article
in En
| MEDLINE
| ID: mdl-38421043
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
J Eur Acad Dermatol Venereol
Journal subject:
DERMATOLOGIA
/
DOENCAS SEXUALMENTE TRANSMISSIVEIS
Year:
2024
Document type:
Article
Affiliation country: